{"name":"Enzychem Lifesciences Corporation","slug":"enzychem-lifesciences-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"EC-18","genericName":"EC-18","slug":"ec-18","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"EC-18","genericName":"EC-18","slug":"ec-18","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQRFg0VzZJem5rakJ5YXdsN1B5cFpQQThiMXNyN1BUT3B6MlcxU0VlNVVOZUdiR2hOWERJa0FGOG1EcDlwVm81RkxCcTI0YjU2YWw1eGpXQlZOQ1Q1cEEyazlWUXBIeDhrenk5NkNybzNrRDNVSWtyWDM1b19nbEFFbdIBlAFBVV95cUxPWURucnpuTjZsQjBPWVJmYW43VGFlUmlGMURKWDdmOGp0SEI4ZG1jd3FIc1p5d1NDeXBHYi1LYm0wNlE1bDIzUGt6ZDdxVEFWazJoc0xpWmEydFkzNlMxUzdyMERhelV1OHhlNkRwVVdaZURYVkhDZjlmZU9FTm90b0x4MjRYalhkN1B1YUJwTGdieTNl?oc=5","date":"2025-05-26","type":"pipeline","source":"Chosunbiz","summary":"Celltrion increases free capital with new share allocation for shareholders - CHOSUNBIZ - Chosunbiz","headline":"Celltrion increases free capital with new share allocation for shareholders - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOMVo2MzBuTmpGeGY1UlQ3d2xFZjdiT1ZRNW9lTUFRRk9DMEZwZ0ZqRm52dldpNnZKRk10WV9VYXVvSXh1ZkdlMGxjVEhKclBsZUJxRDU2WmVqLW82UnZUQVE3a0ZPMnlPRDlMQjBVeEdMVlNRdjZjNTJxQWl6TTNrX01SdS1vci11di1vUmlXNGI5TFgtWDJqTkM4SWdEWDF6UXI2dThnR29XOGZ0QkYwdzA5TzJvQkUtMmZaTVZKd2FfYTNhSVRlMGFhcEc1dGxJMGl2Ym5pcHBnZU93Y3A4clF4OWRGUFB6ZHJaVXhISQ?oc=5","date":"2024-06-11","type":"pipeline","source":"prnewswire.com","summary":"Global Anti-Radiation Drugs Market to Register Incremental Growth at a CAGR of ~9% by 2030 | DelveInsight - prnewswire.com","headline":"Global Anti-Radiation Drugs Market to Register Incremental Growth at a CAGR of ~9% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNSFpwZHB0Q2tFVWxfMmU5T3RBaEFoMDVYV2JZUUIxV2psNUJyakhydUN3SVZnQncyVzd4X0lSb0JKeEwxYXZ2Vi02U19DY0hkTC1FYm9yeXZqc2Y4aTI5Zm5TU0QydGltaEJSaFBvVEgwME0ycEUwRjB5MGh6NGliZlZYN2pUUVR4Q2JPaEhERGw1dGc5a2EyQnMzMWxFa0R1UEdUbS11MHZaYk9aMERmVDBmRmZzYXM?oc=5","date":"2024-03-28","type":"deal","source":"Pharmaceutical Technology","summary":"ReAlta signs deal with NIAID to develop drug for radiation poisoning - Pharmaceutical Technology","headline":"ReAlta signs deal with NIAID to develop drug for radiation poisoning","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9KdnBVcWl0WEhXU3U0MWlQZzJnYURDRTBOcDR3UURmSDdhOUl1UTZZN0ZpSGdIMnB3V3BEbVBIcVhLdGdWZk03ekV1Y0Jmanpkdm5lWWVTLVN6dlNxcTZuS3M5VHM3ZFVpNE5tVEZB0gFyQVVfeXFMTnI2VHVwTDhxN1RoMW93NmwzZnB3b2FQX0ZyNmQwamhIMWkwbEVfRHgzTzhoaXR2bWc3QkJybWtzLV9MaHpoYVMtQVcybXZKdlA3SjRuVTZ0clNaWGtEbnJ3VTBJeFJUS0s4QWNEOXpqeWdn?oc=5","date":"2023-10-25","type":"pipeline","source":"koreabiomed.com","summary":"[CPHI 2023] K-pharma, K-bio companies going global - koreabiomed.com","headline":"[CPHI 2023] K-pharma, K-bio companies going global","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-05-17","type":"pipeline","source":"Syracuse.com","summary":"How sale of Bristol’s East Syracuse pharma plant to Lotte could be a boon to Central NY - Syracuse.com","headline":"How sale of Bristol’s East Syracuse pharma plant to Lotte could be a boon to Central NY","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxORXJ1VXp3MUhaajJ2dWwwbUxPNjFhNmMzLWlneWFQUjJHVGJkdnlLTUlfUW5jLWNvUW1iS0oyX29RNmlkd1ZxNXFkRmJJMG9yUUg2b1R3MFFBTTZmclhUaFZqbDhweTlSVHliRG5jek91OEFXNnZHU0ZaU01ndG9lVlB1aXBFYU1oOGR6d2lyNVIwaTlWaHJVRmszRktIZjF2NEFLdDR2dm1JV3F60gGzAUFVX3lxTE1EdHdDTDFMa1p1cEtycUJidElMMDNkVHhMVGo5LXNoQXkwYlQxSks4WDBHUWRLS09LNDdhSVQ4Q2JPanFVeDJuTk9LS2JXN2tYcWx1Rmt5eHlJMU1rbjctcTJaZVRiWnloTzlxVDFjNmJkUk14cnhjbi1BeU5WS0Rpa3V5eVYzSWxQdXd4UG0zQVZidFZhRnFmVkVCcEZ3RnhRVm9Kd2ttemZvc2dsZTlEVHV3?oc=5","date":"2022-02-02","type":"pipeline","source":"Indian Pharma Post","summary":"Zydus supplies first consignment of its Covid-19 vaccine ZyCoV-D - Indian Pharma Post","headline":"Zydus supplies first consignment of its Covid-19 vaccine ZyCoV-D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBmLWF6Znl3ZG5LOG9feFF6WnJ6RER5bFBtNTdSXzhKRXRLSVo5RXY3TW1KNEpSN3RkOHMyVHZ6bDdPVVV6VTRqcnlLZDNiZEhVM1Y1MW9VOGNFN1UxS0t6U0hrSG8?oc=5","date":"2021-03-22","type":"pipeline","source":"아시아경제","summary":"Lotte to Enter Bio Industry... \"Discussing Investment in Enzychem Lifesciences\" - 아시아경제","headline":"Lotte to Enter Bio Industry... \"Discussing Investment in Enzychem Lifesciences\" - 아시아경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE5pd19femJqMVZpMVlJb0dTUll5SG5qUzJId2RJMXJEdE5UbWpzT3NZYTRkaW9iUDJRSUN6U2pyajJBVmN4dEF2ZDFwMlctcUgwek96aDZHRG1SX29XZmtBdXpuU3g?oc=5","date":"2020-06-16","type":"pipeline","source":"아시아경제","summary":"Enginechem Life Sciences, Active Community... Stock Price Up 7.72%. - 아시아경제","headline":"Enginechem Life Sciences, Active Community... Stock Price Up 7.72%. - 아시아경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxORG84dnEzbkQzb3VreWEtd3c3RjhZQUdkNWpVWW9DSFNJS0M0eXBUZ20ybEtFV2NCZnM1ckF4ZE0xMldTVTVvTlItenA5Ymk2MU11RVkzYW80WUF0UUY0ZjNtTmEtSzZjNDVva2htbHV2c1J1VUFvRnhGXzFuTzBBSHdCR05WU09fSXgzX0NJWWFpU016VnF5UnBCMmh2WURPZUZPTzZZWU1yYWVmMnZBTW45RkJNSGpOcEo4ZzFYbFZTcFZJLXpuV1ZoRGFiZjB6TlRj?oc=5","date":"2019-02-21","type":"trial","source":"prnewswire.com","summary":"Enzychem Lifesciences Completes Stage 1 Patient Enrollment in Phase 2 CRIOM Study - prnewswire.com","headline":"Enzychem Lifesciences Completes Stage 1 Patient Enrollment in Phase 2 CRIOM Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQVW9wcms1bWlUeXltRkh2TktEalpvN2VMZTNvengzeUVsam8tR18tcE5XTWFXRWZLUzBhWFFFY0h6aWN1UHFuMEI5TUlxWTBKMWdWTlFmYXdqVlZRNVhuakxSaGRFU3hqVjVTak51VTJpS0NJSGppbzU4N3c5VFdPZDJLRm9yU0R5ZDRScVJSa08?oc=5","date":"2018-07-05","type":"earnings","source":"Pharmaceutical Executive","summary":"Why One Korean Biotech Picked New Jersey for U.S. Headquarters - Pharmaceutical Executive","headline":"Why One Korean Biotech Picked New Jersey for U.S. Headquarters","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}